PAVmed (PAVM)
(Delayed Data from NSDQ)
$1.15 USD
-0.13 (-10.16%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1.14 -0.01 (-0.87%) 7:32 PM ET
2-Buy of 5 2
F Value B Growth B Momentum D VGM
Cash flow Statements
Fiscal Year End for PAVmed Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -79.26 | -103.24 | -56.13 | -35.89 | -17.27 |
Depreciation/Amortization & Depletion | 2.93 | 2.46 | 0.23 | 0.02 | 0.01 |
Net Change from Assets/Liabilities | 1.59 | -0.72 | -1.57 | 0.08 | -0.06 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 22.70 | 30.51 | 16.88 | 13.87 | 3.96 |
Net Cash From Operating Activities | -52.04 | -70.99 | -40.59 | -21.91 | -13.36 |
Property & Equipment | -0.24 | -1.54 | -1.47 | -0.06 | -0.03 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -3.20 | -2.25 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.76 | -4.74 | -3.72 | -0.06 | -0.03 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 21.25 | 2.98 | 126.26 | 16.41 | 5.55 |
Issuance (Repayment) of Debt | 9.92 | 35.23 | -14.97 | 16.70 | 5.94 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -6.98 | -0.10 | -0.10 |
Net Cash from Financing Activities | 31.17 | 38.21 | 104.31 | 33.01 | 11.38 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -20.11 | -37.51 | 60.00 | 11.04 | -2.00 |
Cash at Beginning of Period | 39.74 | 77.26 | 17.26 | 6.22 | 8.22 |
Cash at End of Period | 19.64 | 39.74 | 77.26 | 17.26 | 6.22 |
Diluted Net EPS | -9.16 | -14.99 | -9.75 | -10.94 | -8.25 |
Fiscal Year End for PAVmed Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -33.43 | -18.51 | -79.26 | -61.86 | -40.11 |
Depreciation/Amortization & Depletion | 0.89 | 0.59 | 2.93 | 2.21 | 1.47 |
Net Change from Assets/Liabilities | -0.04 | 0.38 | 1.59 | -0.53 | -1.92 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.81 | 4.44 | 22.70 | 20.02 | 11.48 |
Net Cash From Operating Activities | -24.77 | -13.11 | -52.04 | -40.16 | -29.07 |
Property & Equipment | -0.05 | -0.04 | -0.24 | -0.06 | -0.04 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 |
Net Cash from Investing Activities | -0.05 | -0.04 | 0.76 | 0.94 | 0.96 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 31.20 | 19.37 | 21.25 | 15.89 | 15.53 |
Issuance (Repayment) of Debt | -0.53 | -0.32 | 9.92 | 10.00 | 10.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 30.67 | 19.05 | 31.17 | 25.89 | 25.53 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 5.86 | 5.90 | -20.11 | -13.34 | -2.58 |
Cash at Beginning of Period | 19.64 | 19.64 | 39.74 | 39.74 | 39.74 |
Cash at End of Period | 25.50 | 25.54 | 19.64 | 26.41 | 37.16 |
Diluted Net EPS | -1.19 | -2.62 | -1.96 | -2.40 | -2.10 |